Tadahiro Shoji

1.3k total citations
84 papers, 885 citations indexed

About

Tadahiro Shoji is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, Tadahiro Shoji has authored 84 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Reproductive Medicine, 32 papers in Surgery and 26 papers in Obstetrics and Gynecology. Recurrent topics in Tadahiro Shoji's work include Ovarian cancer diagnosis and treatment (41 papers), Endometrial and Cervical Cancer Treatments (24 papers) and Intraperitoneal and Appendiceal Malignancies (16 papers). Tadahiro Shoji is often cited by papers focused on Ovarian cancer diagnosis and treatment (41 papers), Endometrial and Cervical Cancer Treatments (24 papers) and Intraperitoneal and Appendiceal Malignancies (16 papers). Tadahiro Shoji collaborates with scholars based in Japan, China and United States. Tadahiro Shoji's co-authors include Toru Sugiyama, Yonghao Lu, Masahiro Kagabu, Satoshi Takeuchi, Tsukasa Baba, Q.J. Peng, Toyoto Sato, Bin Yang, Jiansheng Li and Zihao Wang and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Tadahiro Shoji

74 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tadahiro Shoji Japan 17 310 240 238 176 161 84 885
Yong Beom Kim South Korea 15 259 0.8× 125 0.5× 146 0.6× 102 0.6× 44 0.3× 43 572
Gooike W. van Slooten Netherlands 9 798 2.6× 329 1.4× 35 0.1× 1.7k 9.9× 65 0.4× 12 2.0k
Haoping Xu China 13 13 0.0× 79 0.3× 32 0.1× 107 0.6× 65 0.4× 39 428
Leonidas Sakkas Greece 17 119 0.4× 146 0.6× 97 0.4× 202 1.1× 35 0.2× 27 581
Stefan Zink Germany 13 48 0.2× 79 0.3× 108 0.5× 186 1.1× 157 1.0× 23 761
Wen Luo China 16 47 0.2× 33 0.1× 45 0.2× 138 0.8× 45 0.3× 45 696
Naoki Fukuda Japan 13 14 0.0× 268 1.1× 4 0.0× 135 0.8× 104 0.6× 88 671
Xiaotong Wang China 16 42 0.1× 76 0.3× 58 0.2× 161 0.9× 247 1.5× 41 751
Dong Guo China 19 15 0.0× 368 1.5× 12 0.1× 142 0.8× 249 1.5× 63 1.0k

Countries citing papers authored by Tadahiro Shoji

Since Specialization
Citations

This map shows the geographic impact of Tadahiro Shoji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadahiro Shoji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadahiro Shoji more than expected).

Fields of papers citing papers by Tadahiro Shoji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadahiro Shoji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadahiro Shoji. The network helps show where Tadahiro Shoji may publish in the future.

Co-authorship network of co-authors of Tadahiro Shoji

This figure shows the co-authorship network connecting the top 25 collaborators of Tadahiro Shoji. A scholar is included among the top collaborators of Tadahiro Shoji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadahiro Shoji. Tadahiro Shoji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kagabu, Masahiro, Sho Sato, Tadahiro Shoji, et al.. (2025). Cytokine dynamics and quality of life: unraveling the impact of cell-free and concentrated ascites reinfusion therapy in ovarian cancer patients. International Journal of Clinical Oncology. 30(3). 559–569. 2 indexed citations
2.
3.
Li, Z.H., Lingchong You, Liqiang Wang, et al.. (2025). Stress corrosion cracking behavior and mechanism of scratched Alloy 690TT in lead-containing caustic solution. Corrosion Science. 245. 112702–112702.
4.
Bian, Weixin, et al.. (2024). Effect of fretting wear regimes on stress corrosion cracking of Alloy 690TT in high-temperature pressurized water. Corrosion Science. 237. 112320–112320. 5 indexed citations
5.
6.
7.
8.
Kagabu, Masahiro, et al.. (2020). Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions. International Journal of Molecular Sciences. 21(7). 2335–2335. 62 indexed citations
9.
Shoji, Tadahiro, et al.. (2020). A case of primary ovarian signet-ring cell carcinoma treated with S-1/CDDP therapy. Journal of Ovarian Research. 13(1). 33–33. 2 indexed citations
10.
Nishio, Shin, Munetaka Takekuma, Satoshi Takeuchi, et al.. (2017). Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer. Cancer Science. 108(11). 2213–2220. 21 indexed citations
11.
Sato, Seiya, Masahiro Kagabu, Tadahiro Shoji, et al.. (2017). Gemcitabine and docetaxel in a patient with primary ovarian leiomyosarcoma: a case report and review of literature. International Cancer Conference Journal. 7(1). 11–15. 5 indexed citations
12.
Kagabu, Masahiro, Tadahiro Shoji, Fumiharu Miura, et al.. (2016). Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit Study. International Journal of Clinical Oncology. 21(4). 735–740. 8 indexed citations
13.
Sugai, Tamotsu, et al.. (2016). Molecular Analysis of Single Tumor Glands Using the Crypt Isolation Method in Endometrial Carcinomas. International Journal of Gynecological Cancer. 26(9). 1658–1666. 1 indexed citations
14.
Tokunaga, Hideki, Yoh Watanabe, Yoshihito Yokoyama, et al.. (2016). Advanced squamous cell carcinomas arising from mature cystic teratoma of the ovary: a retrospective case series at the Tohoku Gynecologic Cancer Unit. International Cancer Conference Journal. 5(3). 146–149. 2 indexed citations
15.
Shoji, Tadahiro, Masahiro Kagabu, Fumiharu Miura, et al.. (2016). Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass. International Journal of Clinical Oncology. 21(6). 1120–1127. 15 indexed citations
16.
Takeuchi, Satoshi, Tadahiro Shoji, Masahiro Kagabu, et al.. (2015). ISAC-1-2 A phase I/II study of HLA restricted tumor specific Peptides cocktail vaccine therapy for recurrent ovarian cancer(Group 1 Oncology,IS Award Candidate,International Session). 日本産科婦人科學會雜誌. 67(2). 995.
17.
Shoji, Tadahiro, et al.. (2012). Case of peptide‐YY‐producing strumal carcinoid of the ovary: A case report and review. Journal of obstetrics and gynaecology research. 38(10). 1266–1270. 13 indexed citations
18.
19.
20.
Shimada, Muneaki, Junzo Kigawa, Naoki Terakawa, et al.. (2007). Phase I trial of paclitaxel, doxorubicin, and carboplatin (TAC) for the treatment of endometrial cancer. International Journal of Gynecological Cancer. 17(1). 210–214. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yong Beom Kim Breakdown of academic impact, for papers by Gooike W. van Slooten Breakdown of academic impact, for papers by Haoping Xu Breakdown of academic impact, for papers by Leonidas Sakkas Breakdown of academic impact, for papers by Stefan Zink Breakdown of academic impact, for papers by Wen Luo Breakdown of academic impact, for papers by Naoki Fukuda Breakdown of academic impact, for papers by Xiaotong Wang Breakdown of academic impact, for papers by Dong Guo
Rankless by CCL
2026